NIH News

NIH funding policy on use of human pluripotent cells in regenerative medicine

The field of regenerative medicine continues to expand, seeking potential therapies for replacing, rejuvenating, or engineering human cells to restore function. This line of research often involves the use of human pluripotent cells – “master” stem cells with the potential to produce any cell or tissue in the body and also capable of self-renewal. Work in this field has led researchers to consider introducing pluripotent cells to early-stage animal embryos to grow human tissue and organs. … Read More

NIH-funded core facilities – future directions and OHSU’s model

As you know, Sally Rockey has stepped down from her position at NIH where she steered the Office of Extramural Research for five years. During Rockey’s tenure, she launched a blog, “Rock  Talk,” that lent transparency to NIH decision making and allowed the research community to voice their opinions. In her last few Rock Talk postings, Rockey shared some insights and updates on current NIH priorities and resources including a discussion on NIH-supported core facilities. … Read More

NIH seeks input on 5-year strategic plan

The National Institutes of Health is inviting comments and suggestions on a framework for the NIH-wide Strategic Plan. In response to a request from Congress, NIH is developing a comprehensive 5-year Strategic Plan with input from senior leadership and staff from all 27 Institutes, Centers, and Offices (ICOs). NIH is also calling for contributions from the research community on the proposed framework that identifies priority areas of research and a set of principles to guide the NIH over … Read More

NIH wants your input on new child health program

The NIH is looking for input to help shape its funding priorities for new programming focused on environmental and pediatric health. If you were part of the now discontinued National Children’s Study (NCS), your feedback may be of particular interest. Moving forward, the NIH wants to leverage and expand on existing cohorts established under the NCS to address new research questions related to Environmental Influences on Child Health Outcomes (ECHO). The focus will be on … Read More

West Nile virus vaccine developed at OHSU enters human clinical trials

A new NIH-funded investigational vaccine to protect against West Nile Virus, discovered and developed by OHSU researchers, is entering Phase I clinical trials. The OHSU team, led by Mark Slifka, Ph.D., created the test vaccine, called HydroVax-001, with a novel hydrogen peroxide-based approach that renders the virus inactive while maintaining its integrity; an intact surface structure permits triggering of an immune response to cells infected with the virus. This preparation will allow the test vaccine to be administered to … Read More

Maintaining integrity in peer review: new NIH guidelines

Do you know someone on the study section reviewing your NIH application? Do you want to give them a friendly call to update them on your current results? The NIH says DON’T! Because the research community is inherently small, investigators within the same field often have contact with the very people who may be reviewing their NIH applications. How then should confidentiality be maintained? What are the parameters? Last week, the NIH issued new guidelines … Read More

The NIH takes on the challenge of reproducibility: new requirements for 2016

Coming this fall, you will see changes to application instructions for NIH grant applications. Advances in science are built upon previous observations and findings: that’s why replication and corroboration of research results are essential to the scientific process. In response to continued failures in the reliability and reproducibility of published research, the NIH has been analyzing possible causes and exploring potential interventions for some time. A series of pilot projects were run over the past … Read More

Considering sex as a biological variable; new NIH requirement effective Jan. 2016

Women comprise slightly more than half of the population–and their representation is relatively well balanced in NIH-sponsored clinical research, where they now account for roughly half of all participants. But this shift has not occurred in the preclinical realm. Today, most NIH-sponsored animal studies are focused on males, and many investigators do not report on the sex of the subjects from whom cells are obtained for cell line work. This lack of balance may obscure … Read More

Sally Rockey to depart NIH for Foundation for Food and Agricultural Research

This week, National Institutes of Health Director Francis S. Collins announced that Sally Rockey, Ph.D., will depart NIH to become the director of the Foundation for Food and Agriculture Research. Rockey has served as the deputy director for extramural research for NIH since 2008. The Foundation for Food and Agriculture Research was authorized by the 2014 Farm Bill; it will support research on a range of issues from plant and animal health to agricultural and … Read More

NIGMS wants to hear from you!

The National Institute of General Medical Sciences examining innovative ways to best support biomedical researchers. Last week we reported on NIGMS’s new funding mechanism for early-career scientists and now they’re seeking input on how best to foster technology development for the research community. More specifically, the Institute is asking for information on the need for development of technologies and the relationship of technology development to other biomedical research. Of particular interest are ideas about: The value … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.